HCG (Human Chorionic Gonadotropin).
Glycoprotein hormone — LH-mimetic, used to stimulate endogenous testosterone and fertility.
Build your bag, then either book a consultation (an EU-licensed physician reviews your file — anything declined is refunded) or upload an existing Rx at checkout.
- ✓Magistral preparation — Directive 2001/83/EC Art. 5(1).
- ✓Patient-named prescription only — dispensed against a valid Rx.
- ✓EU-GMP Annex 1 Grade A/B cleanroom compounding.
- ✓Cold-chain shipping across EU/EEA — 2–5 working days.
About HCG (Human Chorionic Gonadotropin).
HCG is a glycoprotein hormone produced by the placenta. Its α-subunit is shared with LH; its β-subunit is unique. Recombinant and urinary-derived HCG hold Marketing Authorisations across the EU for ovulation induction and male hypogonadism.
Magistral use covers physician-directed protocols for HPG-axis recovery, fertility preservation during TRT and downstream testicular support.
HCG binds the LH/CG receptor on Leydig cells in the testis and theca cells in the ovary. Activation drives testosterone or estradiol biosynthesis, mimicking the action of LH. The half-life is longer than LH (~24 hours).
Subcutaneous or intramuscular injection. Doses vary widely: 250–500 IU 2–3 times per week for HPG-axis support; up to several thousand IU for ovulation induction.
Your physician sets the prescription. This is descriptive information, not a self-administration guide.
Lyophilised: store at 2–8 °C, protect from light. Once reconstituted: 2–8 °C, use within 30 days. Do not freeze.
- INN / Name
- HCG (Human Chorionic Gonadotropin)
- Form
- Lyophilised vial · subcutaneous injection
- Strength
- 2000IU vial
- Manufacturing
- EU-GMP Annex 1 · Grade A/B
- Endotoxins
- European Pharmacopoeia 2.6.14 · LAL assay
- Identity & purity
- HPLC + MS · > 98%
- Cold chain
- Validated 2–8 °C, monitored end-to-end
- Regulatory basis
- Directive 2001/83/EC · Article 5(1)
2–5 working days
EU / EEA cold-chain delivery, 2–8 °C monitored end-to-end with digital temperature log. Tracking link sent on dispatch.
Magistral preparation
Patient-named preparation under Directive 2001/83/EC Article 5(1). Dispensed exclusively against a valid EU prescription.
EU prescription recognition
Prescriptions written in one EU member state are recognised in others under Directive 2011/24/EU on cross-border healthcare.